FDA Approves Rezurock (belumosudil) for the Treatment of Patients with Chronic Graft-Versus-Host Disease (cGVHD) NEW YORK, NY / ACCESSWIRE / July 16, 2021 / Kadmon Holdings, Inc. (Nasdaq:KDMN) today announced that the U.S. Food and Drug Administration (FDA) has approved Rezurock™ (belumosudil) 200 mg once daily (QD) for the treatment of adult and pediatric patients… Read More »
Advertisement Continue reading the main story Supported by Continue reading the main story How to Have a Fun, Multigenerational Family Vacation Sometimes a trip with small children means the same chores in a different place. Here’s advice on how to make it a vacation. With 20 family members on their latest vacation, Emily Morgan’s family… Read More »
KHN senior Colorado correspondent Markian Hawryluk discussed how a rural Colorado town is crowdsourcing ways to get prescription medicines delivered on KUNC’s “Colorado Edition” on Monday. KHN Editor-in-Chief Elisabeth Rosenthal discussed how medical education changed during the pandemic on NPR’s “Here and Now” on Tuesday. KHN freelancer Amy Worden chatted about high vaccine hesitancy among… Read More »
YEREVAN, Armenia — In Iran, the urgency of getting vaccinated against COVID-19 is growing by the day. A crush of new cases fueled by the fast-spreading delta variant has threatened to overwhelm Iranian hospitals with breathless patients too numerous to handle. But as deaths mount, and the sense swells that protection for most citizens remains… Read More »
Dr. Scott Gottlieb told CNBC on Friday he believes the U.S. is significantly undercounting the number of Covid delta infections, making it difficult to know whether the highly transmissible strain is causing higher-than-expected hospitalization and death rates. “We don’t know what the denominator is right now,” Gottlieb said in an interview on “Squawk Box.” “I… Read More »